CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Chengdu Taihe Health Technology Group Inc Ltd Company Snapshot
Chengdu Taihe Health Technology Group Inc Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Chengdu Taihe Health Technology Group Inc Ltd with three other companies in this sector in China: Hainan Poly Pharm Co Ltd (2018 sales of 623.90 million Chinese Renmimbi [US$87.48 million] of which 39% was Antiallergic drugs), Beijing Beilu Pharmaceutical Company Limited (608.05 million Chinese Renmimbi [US$85.26 million] of which 100% was Pharmaceutical Sales), and Jilin Province Huinan Changlong Bio-pharmacy Co Ltd (647.67 million Chinese Renmimbi [US$90.81 million] of which 100% was Manufacture and distribution of Chinese ).

Sales Analysis. During the year ended December of 2018, sales at Chengdu Taihe Health Technology Group Inc Ltd were 633.42 million Chinese Renmimbi (US$88.81 million). This is an increase of 7.2% versus 2017, when the company's sales were 590.95 million Chinese Renmimbi. This was the third consecutive year of growth at Chengdu Taihe Health Technology Group Inc Ltd. The sales level in 2018 was fairly close to the level five years ago: in 2013, Chengdu Taihe Health Technology Group Inc Ltd had sales of 655.88 million Chinese Renmimbi. Sales of Others saw an increase that was more than double the company's growth rate: sales were up 28.3% in 2018, from 1.12 million Chinese Renmimbi to 1.44 million Chinese Renmimbi. Chengdu Taihe Health Technology Group Inc Ltd also saw significant increases in sales in Medicine Manufacturing (up 16.7% to 591.79 million Chinese Renmimbi) . Not all segments of Chengdu Taihe Health Technology Group Inc Ltd experienced an increase in sales in 2018: sales of Steel Structure Design and Manufacturing fell 51.5% to 40.18 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Chengdu Taihe Health Technology Group Inc Ltd
  Stock Performance Chart for Chengdu Taihe Health Technology Group Inc Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 4.38
(Figures in Chinese Renmimbi)
1 Week 5.0%   13 Weeks -3.3%  
4 Weeks 0.9%   52 Weeks 15.8%  
 
Chengdu Taihe Health Technology Group Inc Ltd Key Data:
  Ticker: 000790 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 633,417,693
(Year Ending Jan 2019).
Employees: 702
  Currency: Chinese Renmimbi Market Cap: 2,699,659,270
  Fiscal Yr Ends: December Shares Outstanding: 616,360,564
  Share Type: A Gu Closely Held Shares: 179,664,472
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.